Health Officials Investigating Possible Link Between Ozempic and Eye-Rotting Condition
Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...
FDA Says Shortage of Eli Lilly’s Zepbound is Over, But Gives Compounders a Grace Period
The Food and Drug Administration said Thursday that the longstanding shortage of Eli Lilly’s weight-loss drug Zepbound and ...